| NOVEMBER, 2014 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
| CHEMISTRY: ELECTRICAL AND WAVE ENERGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,882,978 | FAD-conjugated glucose dehydrogenase gene | Ikeda Food Research Co., Ltd. | 11-Nov-14 | Japan |
| CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,889,644 | GNAQ targeted dsRNA compositions and methods for inhibiting expression | Alnylam Pharmaceuticals, Inc. | 18-Nov-14 | United States |
| 8,895,239 | Genetically engineered biological indicator | American Sterilizer Company | 25-Nov-14 | United States |
| 8,883,419 | Methods and kits useful for the identification of astrocytoma, it's grades and glioblastoma prognosis | Council of Scientific & Industrial Research | 11-Nov-14 | India |
| 8,889,390 | Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes | Dow AgroSciences LLC | 18-Nov-14 | United States |
| 8,895,240 | Method, kit and system for collecting and processing samples for DNA and RNA detection | E I du Pont de Nemours and Company | 25-Nov-14 | United States |
| 8,895,269 | Gene expression profiling from FFPE samples | Erlander; Mark G | 25-Nov-14 | United States |
| 8,883,458 | Process for preparing L-amino acids using improved strains of the Enterobacteriaceae family | Evonik Degussa GmbH | 11-Nov-14 | Germany |
| 8,895,237 | Enhancing of hepatitis B virus vaccine and its gene | Fudan University | 25-Nov-14 | China P. Rep. |
| 8,883,416 | Isolated reductive dehalogenase genes | Georgia Tech Research Corporation | 11-Nov-14 | United States |
| 8,883,483 | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes | GlycoFi, Inc. | 11-Nov-14 | United States |
| 8,877,462 | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes | GlycoFi, Inc. | 4-Nov-14 | United States |
| 8,895,246 | Nucleic acid detection method | Hitachi High-Technologies Corporation | 25-Nov-14 | Japan |
| 8,895,268 | Preservation of information related to genomic DNA methylation | Illumina, Inc. | 25-Nov-14 | United States |
| 8,883,418 | Measurement of the immunological diversity and evaluation of the effects of a treatment through studying V(D)J diversity | ImmunID | 11-Nov-14 | France |
| 8,889,410 | Mammalian cell lines for increasing longevity and protein yield from a cell culture | Immunomedics, Inc. | 18-Nov-14 | United States |
| 8,889,419 | Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains | Indiana University Research & Technology Corporation | 18-Nov-14 | United States |
| 8,877,445 | Methods for identification of tumor phenotype and treatment | Intelligent Oncotherapeutics, Inc. | 4-Nov-14 | United States |
| 8,895,306 | Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | Intrexon Corporation | 25-Nov-14 | United States |
| 8,895,276 | Microorganism variants having hydrocarbon producing ability and method for producing hydrocarbon using the same | Korea Advanced Institute of Science and Technology | 25-Nov-14 | Korea |
| 8,877,482 | Homo-succinic acid producing microorganism variant and process for preparing succinic acid using the same | Korea Advanced Institute of Science and Technology | 4-Nov-14 | Korea |
| 8,895,309 | Myostatin inhibition for enhancing muscle and/or improving muscle function | Nationwide Children's Hospital | 25-Nov-14 | United States |
| 8,895,264 | Methods and compositions for modification of the HPRT locus | Sangamo BioSciences, Inc. | 25-Nov-14 | United States |
| 8,895,243 | Method of assessing cancerous conditions and reagent for detecting gene product to be used in the method | Sekisui Medical Co., Ltd | 25-Nov-14 | Japan |
| 8,889,402 | Chlorella species containing exogenous genes | Solazyme, Inc. | 18-Nov-14 | United States |
| 8,889,397 | Nucleotides for prevention and treatment of bacterial and fungal pathologies | Star Biologics, Inc. | 18-Nov-14 | United States |
| 8,889,361 | Gene expression signatures in enriched tumor cell samples | The Research Foundation for The State University of New York | 18-Nov-14 | United States |
| 8,877,443 | Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody | The University of Tokyo | 4-Nov-14 | Japan |
| 8,877,504 | Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule | Universite Libre de Bruxelles | 4-Nov-14 | Belgium |
| 8,895,248 | Method for detecting Salmonella species by assaying outer membrane Porin F (ompF) | University of South Florida | 25-Nov-14 | United States |
| COMBINATORIAL CHEMISTRY TECHNOLOGY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,883,692 | Method for cell surface displaying of target proteins using Bacillus anthracis exosporium | Korea Advanced Institute of Science and Technology | 11-Nov-14 | United States |
| DATA PROCESSING | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,880,350 | System and method for determining individualized medical intervention for a disease state | Caris MPI, Inc. | 4-Nov-14 | United States |
| DRUG | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,877,726 | Method and medicament for inhibiting the expression of a given gene | Alnylam Pharmaceuticals, Inc. | 4-Nov-14 | United States |
| 8,883,813 | Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes | Amacus Therapeutics, Inc. | 11-Nov-14 | United States |
| 8,877,264 | Composition of skin external application containing ginseng berry extracts | Amorepacific Corporation | 4-Nov-14 | Korea |
| 8,889,743 | Inhibition of filovirus entry into cells and uses thereof | Board of Regents, University of Texas System | 18-Nov-14 | United States |
| 8,895,526 | Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers | Cold Spring Harbor Laboratory | 25-Nov-14 | United States |
| 8,883,150 | Soluble "heavy-chain only" antibodies | Erasmus University Medical Center | 11-Nov-14 | Netherlands |
| 8,877,722 | Compositions for inhibiting gene expression and uses thereof | Idera Pharmaceuticals, Inc. | 4-Nov-14 | United States |
| 8,895,000 | Methods for inhibiting the binding of endosialin to ligands | Morphotek, Inc. | 25-Nov-14 | United States |
| 8,889,147 | DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein | National Tsing Hua University | 18-Nov-14 | Taiwan |
| 8,894,996 | Immunoadjuvant composition and use thereof | Osaka University | 25-Nov-14 | Japan |
| 8,883,161 | Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant | Protein Design Lab, Ltd. | 11-Nov-14 | China P. Rep. |
| 8,889,150 | Bacterial vaccine components from Staphylococcus aureus and uses thereof | SOCPRA--Sciences et Genie, s.e.c | 18-Nov-14 | United States |
| 8,877,721 | Small activating RNA molecules and methods of use | The Regents of the University of California | 4-Nov-14 | United States |
| 8,877,213 | Live attenuated Leishmania vaccines | The United States of America as Represented by the Secretary of the Department of Health and Human Services | 4-Nov-14 | United States |
| 8,883,744 | Method and composition for modulating canonical Wnt pathway using folate and inositol | University of South Florida | 11-Nov-14 | United States |
| MULTICELLULAR LIVING ORGANISMS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,884,095 | Animal models of neurological disorders | Ann & Robert H. Lurie Children's Hospital of Chicago | 11-Nov-14 | United States |
| 8,889,949 | Method for increasing resistance of monocot plants against abiotic stresses, TPSP fusion enzyme gene constructs, and transformants | Cornell Research Foundation, Inc. | 18-Nov-14 | United States |
| 8,884,101 | Method of gene introduction into Triticum plant using Agrobacterium, and a method of producing transformed Triticum plant | Japan Tobacco Inc | 11-Nov-14 | Japan |
| 8,895,807 | RabG3b gene and protein thereof for regulating late stage xylem development, method for promoting plant biomass and transgenic plant comprising the same | Korea University Research and Business Foundation | 25-Nov-14 | Korea |
| 8,884,126 | Corn variety DE811ASR(BC5) | Pioneer Hi-Bred International Inc | United States | |
| 8,895,802 | Genetically modified mice that produce hybrid antibodies | Regeneron Pharmaceuticals Inc. | 25-Nov-14 | United States |
| 8,895,801 | Methods of producing hybrid antibodies | Regeneron Pharmaceuticals Inc. | 25-Nov-14 | United States |
| 8,878,001 | Humanized IL-6 and IL-6 receptor | Regeneron Pharmaceuticals, Inc. | 4-Nov-14 | United States |
| 8,895,805 | Method for modifying insect resistance of plants by utilizing RNAi technique | Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences | 25-Nov-14 | China P. Rep. |
| NATURAL RESINS OR DERIVATIVES | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,895,703 | CA125 gene and its use for diagnostic and therapeutic interventions | The Board of Trustees for the University of Arkansas | 25-Nov-14 | United States |
| ORGANIC COMPOUNDS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,877,912 | Nucleic acids encoding fungal serine protease | AB Enzymes Oy | 4-Nov-14 | Finland |
| 8,877,917 | Glycoconjugates of RNA interference agents | Alnylam Pharmaceuticals, Inc | 4-Nov-14 | United States |
| 8,877,910 | Probe for detecting polymorphism in exon 12 of NPM1 gene and use thereof | Arkray, Inc. | 4-Nov-14 | Japan |
| 8,877,911 | Methods and compositions for analyzing AHASL genes | BASF SE | 4-Nov-14 | Germany |
| 8,877,916 | Promoter, promoter control elements, and combinations, and uses thereof | Ceres, Inc. | 4-Nov-14 | United States |
| 8,883,996 | Methods and compositions for the specific inhibition of gene expression by double-stranded RNA | City of Hope | 11-Nov-14 | United States |
| 8,877,727 | Delivery of dsRNA to arthropods | Commonwealth Scientific and Industrial Research Organisation | 4-Nov-14 | Australia |
| 8,883,754 | Method for inhibiting angiogenesis | Ewha University--Industry Collaboration Foundation | 11-Nov-14 | Korea |
| 8,883,993 | Tetraselmis promoters and terminators for use in eukaryotic cells | ExxonMobil Research and Engineering Company | 11-Nov-14 | United States |
| 8,884,060 | Process of preparing chiral diacylhydrazine ligands | Intrexon Corporation | 11-Nov-14 | United States |
| 8,895,718 | RNA interference mediating small RNA molecules | Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V | 25-Nov-14 | Germany |
| 8,895,721 | RNA interference mediating small RNA molecules | Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. | 25-Nov-14 | United States |
| 8,895,523 | Use of antisense oligonucleotides against CPLA2 in the treatment of cancer | Mor Research Applications Ltd. | 25-Nov-14 | Israel |
| 8,877,915 | Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factor | National Institute of Advanced Industrial Science and Technology | 4-Nov-14 | Japan |
| 8,889,844 | Nucleic acid for treatment or prevention of immunodeficiency virus infection | Takara Bio Inc. | 18-Nov-14 | Japan |
| 8,883,998 | siRNA targeting myeloid differentiation primary response gene (88) (MYD88) | Thermo Fisher Scientific Inc. | 11-Nov-14 | United States |
| 8,895,525 | Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic RNAs | University of Southern California | 25-Nov-14 | United States |
| SURGERY | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,894,696 | Suprachiasmatic nucleus inducing, melatonin suppressing light emitting device to enhance wake cycle | Hurst; Katherine L | 25-Nov-14 | United States |
Login
To traslate this page, click a flag!
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
